| 000 | 01469 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513233925.0 | ||
| 264 | 0 | _c20010412 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aO'Donnell, R T | |
| 245 | 0 | 0 |
_aA phase I study of 90Y-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a3647-55 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Heterophile _xblood |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma, Non-Hodgkin _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aRadioimmunotherapy _xadverse effects |
| 650 | 0 | 4 | _aRadionuclide Imaging |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aThrombocytopenia _xetiology |
| 650 | 0 | 4 |
_aYttrium Radioisotopes _xadverse effects |
| 700 | 1 | _aShen, S | |
| 700 | 1 | _aDenardo, S J | |
| 700 | 1 | _aWun, T | |
| 700 | 1 | _aKukis, D L | |
| 700 | 1 | _aGoldstein, D S | |
| 700 | 1 | _aDenardo, G L | |
| 773 | 0 |
_tAnticancer research _gvol. 20 _gno. 5C _gp. 3647-55 |
|
| 999 |
_c11204595 _d11204595 |
||